Pharmafile Logo
Pharmafocus logo
Advanced Search

generics

Showing 15 posts of 209 posts found.

Leading pharmaceutical companies sued in US for conspiring to drive up generics prices

June 11, 2020
Business Services drugs, generics, lawsuit, price fixing, price-fixing

26 pharmaceutical companies are being sued by most US states for allegedly conspiring to reduce competition and drive up generic …

News
drugs

Trump signs deal with generics company Phlow Corp to help shift drug manufacturing to the US

May 19, 2020
Manufacturing and Production APIs, COVID-19, Drugs manufacturing, coronavirus, generics

The Trump administration will sign a $354 million deal with the generics company Phlow Corp to help produce medicines and …

News
ny

How the intended role of generic medicines is being undermined in America

April 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, US, feature, generic medicines, generics

The introduction of a generic medicine should, in theory, incentivise companies to lower the price of the original drug, creating healthy …

Feature
1024px-u

Novartis’ subsidiary Sandoz agrees to pay $195 million to settle antitrust case

March 3, 2020
Manufacturing and Production Novartis, US Courts, generic drugs, generics, price fixing, price-fixing

Novartis’ Sandoz will pay a $195 million criminal penalty to resolve charges that it conspired to price-fix, rig bids and …

News
martin_shkreli_2016

FDA approves first generic version of Shkreli-hiked toxoplasmosis drug Daraprim

March 2, 2020
Sales and Marketing Cerovene, Daraprim, FDA, Martin Shkreli, generics, pharma

The FDA has awarded approval to the first generic medicine for the treatment of toxoplasmosis, authorising Cerovene’s version of Daraprim …

News
novartis_gilenya_multiple_sclerosis_2

FDA approves first three generic versions of Novartis’ Gilenya for relapsing multiple sclerosis

December 6, 2019
Medical Communications, Sales and Marketing Novartis, generics, gilenya, multiple sclerosis, pharma

The FDA has approved the first three generic versions of Novartis’ sphingosine 1-phosphate receptor modulator Gilenya (fingolimod) to treat adult …

News

Pfizer to combine off-patent drug unit Upjohn with Mylan

July 30, 2019
Manufacturing and Production M&A, MA, Mylan, Pfizer, Upjohn, biosimilars, generics, mergers

Pfizer’s off-patent drug unit Upjohn is combining with Mylan to create a new global pharmaceutical company focused on the low-price …

News
shutterstock_138095450_13

Prices hiked on 3,400 drugs in first half of 2019

July 4, 2019
Research and Development, Sales and Marketing abstruse, access, generics, pharma, prescription, pricing

There have been price hikes on more than 3,400 drugs in the United States in the first six months of …

News
julyaugust_2019_cover

Read the July/August edition of Pharmafocus online now!

June 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Orkambi, Trump, UK, brexit, generics, manufacturing compliance, pharma

The latest monthly edition of Pharmafocus, the July/August issue, is available to read for free online now!The UK remains split …

News

China urges firms to make generic versions of 34 drugs

June 25, 2019
Research and Development China, NHC, generic drugs, generics, patents, pharma

China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …

News
european_commission_web_5

EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms

June 19, 2019
Research and Development EU, counterfeit, generics, pharma, sales

A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …

News
16792957331_d9572dbdf4_z

FDA expand Paragraph IV Patent Certifications List for generic drugmakers

June 19, 2019
Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma

The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …

News
sandoz

Sandoz is first multinational to secure generic approval under new Chinese guidelines

May 20, 2019
Sales and Marketing China, Novartis, Sandoz, generics, pharma, rosuvastatin

Sandoz has revealed that its generic statin rosuvastatin, known in its branded incarnation as Crestor, has been given approval in …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 17, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Gilead, J&J, JJ, Janssen, Mundipharma, Novartis, Teva, generics

Some big names – including Gilead, Janssen, Teva and Bristol-Myers Squibb – were in trouble this week after two separate …

News
teva_copy

US States allege 20 generic drugmakers fixed prices of generic drugs

May 13, 2019
Sales and Marketing competition, generics, markets, price fixing, price-fixing, pricing

Forty-four US States have filed a lawsuit against 20 generic drugmakers – including Teva Pharmaceuticals – over allegations the firms …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024